🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Non-small Cell Lung Cancer Stage IIIB

Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC. NCT06167460n/a1 site📍 Ho Chi Minh City Gene Solutions Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC) NCT07153445Phase 221 sites📍 Alicante📍 Badalona📍 Barcelona Fundación GECP · Tests: Atezolizumab, Paclitaxel, Carboplatin Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation NCT05010109NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: 6 Minute Walk Functional Test, Biospecimen Collection, Computed Tomography, Echocardiography, Exercise Cardiac Stress T… Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression NCT06269211Phase 22 sites📍 Guangzhou📍 Shanghai Ruijin Hospital · Tests: Toripalimab SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR Mutations NCT06080776Phase 31 site📍 Shanghai Nanjing Sanhome Pharmaceutical, Co., Ltd. · Tests: SH-1028 tablets, Placebo SH-1028 tablets Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung Cancer NCT07855965Phase 29 sites📍 Chengdu📍 Chengdu📍 Chengdu West China Hospital · Tests: Cryo-Thermal Ablation, Toripalimab, Platinum-based doublet chemotherapy A Confirmatory Clinical Study in NSCLC Patients With MET Exon 14 Mutation (KUNPENG-2) NCT05989542Phase 31 site📍 Guangzhou Beijing Pearl Biotechnology Limited Liability Company · Tests: PLB1001 A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET-Positive NCT06930794Phase 32 sites📍 Beijing📍 Guangzhou Beijing Pearl Biotechnology Limited Liability Company · Tests: Vebreltinib combined with platinum-based doublet chemotherapy., platinum-based doublet chemotherapy. A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC NCT06951464Phase 21 site📍 Chengdu Sichuan University · Tests: BL-B01D1, Almonertinib Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer NCT05136846Phase 12 sites📍 Duarte📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Carboplatin, Durvalumab, Paclitaxel, Papaverine, Radiation Therapy Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy NCT04892953Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Carboplatin, Durvalumab, Gemcitabine, Local Consolidation Therapy, Nab-paclitaxel Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC NCT06939127Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Neoadjuvant Cryoablation Combined with Tislelizumab and Chemotherapy, Surgery, Adjuvant tislelizumab A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. NCT06284317Phase 342 sites📍 Camperdown📍 Penrith📍 St Leonards ETOP IBCSG Partners Foundation · Tests: Adjuvant durvalumab Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers NCT03948100NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Educational Intervention, Quality-of-Life Assessment, Questionnaire Administration, Yoga Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant Non-Small-Cell Lung Cancer NCT06734182Phase 21 site📍 Guangzhou Guangdong Provincial People's Hospital · Tests: Envafolimab injections+intravenous Disitamab Vedotin+carboplatin Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC NCT06864624Phase 23 sites📍 Changsha📍 Yinchuan📍 Xi'an Tang-Du Hospital · Tests: Sunvozertinib Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC NCT06532591Phase 21 site📍 Chengdu Sichuan Cancer Hospital and Research Institute · Tests: cadonilimab+paclitaxel/albumin-bound paclitaxel+carboplatin Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC NCT06241807Phase 21 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: Camrelizumab Plus Chemotherapy MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC NCT05286957Phase 21 site📍 Zhengzhou The First Affiliated Hospital of Zhengzhou University · Tests: adjuvant tislelizumab and chemotherapy for MRD+ patients, adjuvant tislelizumab and chemotherapy for MRD+ patients, adj… Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations NCT07195695Phase 3202 sites📍 Fresno📍 Glendale📍 Orange Boehringer Ingelheim · Tests: Zongertinib, Pembrolizumab, Atezolizumab, Durvalumab, Nivolumab A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer NCT05104788Phase 21 site📍 Beijing Peking University Cancer Hospital & Institute · Tests: Icotinib, Cisplatin, Carboplatin, Pemetrexed D-BACE in Combination With Chemotherapy and Camrelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC NCT07016126Phase 21 site📍 Guangzhou Guangdong Provincial People's Hospital · Tests: D-BACE in combination with chemotherapy and karelizumab Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer NCT05061550Phase 297 sites📍 Little Rock📍 Los Angeles📍 Oakland AstraZeneca · Tests: Durvalumab, Oleclumab, Monalizumab, Dato-DXd, AZD0171 MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013) NCT07431827Phase 3117 sites📍 Ciudad Autónoma de Buenos Aires📍 Rosario📍 CABA Merck Sharp & Dohme LLC · Tests: Calderasib, MK-3475A, Placebo Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer NCT06659042Phase 21 site📍 Shanghai Shanghai Chest Hospital · Tests: Tislelizumab, Cisplatin, Carboplatin, Pemetrexed Disodium Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial NCT06096844Phase 3328 sites📍 Fayetteville📍 Fort Smith📍 Rogers National Cancer Institute (NCI) · Tests: Carboplatin, Computed Tomography, Magnetic Resonance Imaging, Nab-paclitaxel, Paclitaxel A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) NCT05920356Phase 3424 sites📍 Santa Barbara📍 Newark📍 Coral Springs Amgen · Tests: Sotorasib, Pembrolizumab Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer NCT07534033Phase 21 site📍 Guangzhou Zhujiang Hospital · Tests: Probiotics combined with neoadjuvant chemoimmunotherapy Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC NCT07309952Phase 21 site📍 Guangzhou Yang Hong · Tests: Sintilimab, Paclitaxel, Carboplatin (AUC 5), Pemetrexed 500 mg/m2, Stereotactic body radiotherapy (SBRT) Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient NCT07198217Phase 21 site📍 Zibo Zibo Municipal Hospital · Tests: SBRT combined with Tislelizumab followed by Tislelizumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy